Clinical Trial Update: Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFs [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating PF-00547659 levels in cerebrospinal fluid lymphocytes in volunteers with Crohn's disease or ulcerative colitis who failed or tolerated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• PF-00547659

Snippet

Sponsor: Shire | Conditions: Crohn's Disease, Ileitis | Phase 1 | Status: COMPLETED | Results posted: 2017-04-26